Abdelbaset Al Megrahi, the Libyan man convicted of the Lockerbie bombing and controversially released last year, is claiming that a Maltese witness at his trial “betrayed a fellow human being for money”.

The claim was made to Jim Swire, a Scottish doctor who last week visited Al Megrahi in Tripoli. Dr Swire lost his daughter in the Lockerbie bombing in 1988.

Al Megrahi was convicted of killing 259 people on board a Pan Am jet with exploded over the Scottish town of Lockerbie, and 11 on the ground.

The two men met in Tripoli last Tuesday where they discussed, among other issues, Tony Gauci, the owner of a shop in Sliema who claimed he had identified Mr Al Megrahi as the man who had bought clothes from him that were later found wrapped around the bomb.

His testimony led to the imprisonment of Mr Al-Megrahi, until the Libyan was released a year ago on compassionate grounds after being diagnosed with advanced prostate cancer.

Asked by The Sunday Times whether the two men spoke about Mr Gauci’s testimony, Dr Swire said: “Yes we did. We felt that if Abdelbaset and I were standing at the gates of heaven, and Mr Gauci applied for entry he would be asked why he had betrayed his brother human being and his only answer would have to be ‘for the money’.”

Mr Al-Megrahi’s defence team recently contended that the Maltese witness was paid “in excess of $2 million”, while his brother was paid “in excess of $1 million” for their cooperation.

Dr Swire said he was convinced of the Libyan’s innocence, saying he was converted by the evidence he heard in the main trial at Camp Zeist.

Dr Swire said Mr Gauci’s evidence was clearly unreliable now that it had emerged (from a policeman’s diary, since made public by Mr Megrahi’s defence team and not seen by the court), that he was enticed with offers of American money to give evidence, which the court was unaware of.

(Full story in The Sunday Times)

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.